Metabolic phenotyping of an adoptive transfer mouse model of experimental colitis and impact of dietary fish oil intake

Journal of Proteome Research

Volumn 14, Issue 4, 2015, Pages 1911-1919

  Martin, Francois Pierre J ^a   Lichti, Pia ^b   Bosco, Nabil ^a   Brahmbhatt, Viral ^a   Oliveira, Manuel ^a   Haller, Dirk ^b   Benyacoub, Jalil ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chemometrics; Fish oil; Inflammatory bowel disease (IBD); Liver; Metabonomics; Nuclear magnetic resonance (NMR) spectroscopy; Omega 3 fatty acids; Plasma; Stool; Urine

Indexed keywords

2 OXOGLUTARIC ACID; FISH OIL; GLUTAMINE; GLYCOPROTEIN; OMEGA 3 FATTY ACID; PLASMALOGEN; SPHINGOMYELIN; SUCCINIC ACID; TRIACYLGLYCEROL; ALPHA-KETOGLUTARIC ACID;

ACUTE PHASE RESPONSE; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; EXPERIMENTAL COLITIS; FECES; LIPOLYSIS; METABOLITE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; T LYMPHOCYTE; URINE; ANIMAL; CHEMISTRY; COLITIS; DIETARY SUPPLEMENT; DRUG EFFECTS; LIVER; METABOLISM; METABOLOME; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PROCEDURES;

ANIMALIA; MUS;

ADOPTIVE TRANSFER; ANIMALS; COLITIS; DIETARY SUPPLEMENTS; FECES; FISH OILS; GLUTAMINE; KETOGLUTARIC ACIDS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; METABOLOMICS; MICE; SUCCINIC ACID; URINE;

EID: 84926432836     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr501299m     Document Type: Article

References (54)

1. Loftus, E. V., Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences Gastroenterology 2004, 126, 1504-17
2. Kaser, A.; Zeissig, S.; Blumberg, R. S. Inflammatory bowel disease Annu. Rev. Immunol. 2010, 28, 573-621
3. Matricon, J.; Barnich, N.; Ardid, D. Immunopathogenesis of inflammatory bowel disease Self/Nonself 2010, 1, 299-309
4. Moco, S.; Candela, M.; Chuang, E.; Draper, C.; Cominetti, O.; Montoliu, I.; Barron, D.; Kussmann, M.; Brigidi, P.; Gionchetti, P.; Martin, F. P. Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism Inflammatory Bowel Dis. 2014, 20, 2104-14
5. Hendrickson, B. A.; Gokhale, R.; Cho, J. H. Clinical aspects and pathophysiology of inflammatory bowel disease Clin Microbiol Rev. 2002, 15, 79-94
6. Carter, M. J.; Lobo, A. J.; Travis, S. P. Guidelines for the management of inflammatory bowel disease in adults Gut 2004, 53, V1-V16
7. Wirtz, S.; Neurath, M. F. Mouse models of inflammatory bowel disease Adv. Drug Delivery Rev. 2007, 59, 1073-1083
8. Wirtz, S.; Neufert, C.; Weigmann, B.; Neurath, M. F. Chemically induced mouse models of intestinal inflammation Nat. Protoc. 2007, 2, 541-546
9. Mizoguchi, A.; Mizoguchi, E. Inflammatory bowel disease, past, present and future: lessons from animal models J. Gastroenterol. 2008, 43, 1-17
10. Sartor, R. B. Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment. Pharmacol. Ther. 1997, 11, 89-96
11. te Velde, A. A.; de Kort, F.; Sterrenburg, E.; Pronk, I.; ten Kate, F. J.; Hommes, D. W.; van Deventer, S. J. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease Inflammatory Bowel Dis. 2007, 13, 325-30
12. Bosco, N.; Brahmbhatt, V.; Oliveira, M.; Martin, F. P.; Lichti, P.; Raymond, F.; Mansourian, R.; Metairon, S.; Pace-Asciak, C.; Bastic Schmid, V.; Rezzi, S.; Haller, D.; Benyacoub, J. Effects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitis Lipids Health Dis. 2013, 12, 81
13. Oliveira, M.; Bosco, N.; Perruisseau, G.; Nicolas, J.; Segura-Roggero, I.; Duboux, S.; Briand, M.; Blum, S.; Benyacoub, J. Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis Clin. Dev. Immunol. 2011, 2011, 807483
14. Dawiskiba, T.; Deja, S.; Mulak, A.; Zabek, A.; Jawien, E.; Pawelka, D.; Banasik, M.; Mastalerz-Migas, A.; Balcerzak, W.; Kaliszewski, K.; Skora, J.; Barc, P.; Korta, K.; Pormanczuk, K.; Szyber, P.; Litarski, A.; Mlynarz, P. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases World J. Gastroenterol. 2014, 20, 163-174
15. Lin, H. M.; Helsby, N. A.; Rowan, D. D.; Ferguson, L. R. Using metabolomic analysis to understand inflammatory bowel diseases Inflammatory Bowel Dis. 2011, 17, 1021-1029
16. Yau, Y.; Leong, R. W.; Zeng, M.; Wasinger, V. C. Proteomics and metabolomics in inflammatory bowel disease J. Gastroenterol. Hepatol. 2013, 28, 1076-1086
17. Cardinale, C. J.; Kelsen, J. R.; Baldassano, R. N.; Hakonarson, H. Impact of exome sequencing in inflammatory bowel disease World J. Gastroenterol. 2013, 19, 6721-6729
18. Hold, G. L.; Smith, M.; Grange, C.; Watt, E. R.; El-Omar, E. M.; Mukhopadhya, I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J. Gastroenterol. 2014, 20, 1192-1210
19. Martin, F. P.; Collino, S.; Rezzi, S.; Kochhar, S. Metabolomic applications to decipher gut microbial metabolic influence in health and disease Front. Physiol. 2012, 3, 113
20. Kussmann, M.; Blum, S. OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers Endocr., Metab. Immune Disord.: Drug Targets 2007, 7, 271-287
21. Martin, F. P.; Rezzi, S.; Philippe, D.; Tornier, L.; Messlik, A.; Holzlwimmer, G.; Baur, P.; Quintanilla-Fend, L.; Loh, G.; Blaut, M.; Blum, S.; Kochhar, S.; Haller, D. Metabolic Assessment of Gradual Development of Moderate Experimental Colitis in IL-10 Deficient Mice J. Proteome Res. 2009, 8, 2376-2387
22. ΔARE/WT Mouse Model J. Proteome Res. 2011, 10, 5523-5535
23. Gruber, L.; Kisling, S.; Lichti, P.; Martin, F. P.; May, S.; Klingenspor, M.; Lichtenegger, M.; Rychlik, M.; Haller, D. High fat diet accelerates pathogenesis of murine Crohns disease-like ileitis independently of obesity PLoS ONE 2013, 8, e71661
24. Schmitz, G.; Ecker, J. The opposing effects of n-3 and n-6 fatty acids Prog. Lipid Res. 2008, 47, 147-55
25. MacLean, C. H.; Mojica, W. A.; Newberry, S. J.; Pencharz, J.; Garland, R. H.; Tu, W.; Hilton, L. G.; Gralnek, I. M.; Rhodes, S.; Khanna, P.; Morton, S. C. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease Am. J. Clin. Nutr. 2005, 82, 611-9
26. Turner, D.; Zlotkin, S. H.; Shah, P. S.; Griffiths, A. M. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohns disease Cochrane Database Syst. Rev. 2009, CD006320
27. Turner, D.; Steinhart, A. H.; Griffiths, A. M. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis Cochrane Database Syst. Rev. 2007, CD006443
28. Brahmbhatt, V.; Oliveira, M.; Briand, M.; Perrisseau, G.; Bastic Schmid, V.; Destaillats, F.; Pace-Asciak, C.; Benyacoub, J.; Bosco, N. Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress J. Nutr. Biochem 2013, 24, 104-11
29. Folch, J.; Lees, M.; Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues J. Biol. Chem. 1957, 226, 497-509
30. Meiboom, S.; Gill, D. Modified spin-echo method for measuring nuclear relaxation times Rev. Sci. Instrum. 1958, 29, 688-691
31. Wu, D. H.; Chen, A. D.; Johnson, C. S. Improved Diffusion-Ordered Spectroscopy Experiment Incorporating Bipolar-Gradient Pulses J. Magn. Reson., Ser. A 1995, 115, 260-264
32. Trygg, J.; Wold, S. O2-PLS, a two-block (X-Y) latent variable regression (LVR) method with an integrated OSC filter J. Chemom. 2003, 17, 53-64
33. 13C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67, 793-811
34. Cabana, V. G.; Siegel, J. N.; Sabesin, S. M. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins J. Lipid Res. 1989, 30, 39-49
35. Getz, G. S.; Reardon, C. A. SAA, HDL biogenesis, and inflammation J. Lipid Res. 2008, 49, 269-270
36. Lindhorst, E.; Young, D.; Bagshaw, W.; Hyland, M.; Kisilevsky, R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse Biochim. Biophys. Acta 1997, 1339, 143-154
37. Rojas-Cartagena, C.; Flores, I.; Appleyard, C. B. Role of tumor necrosis factor receptors in an animal model of acute colitis Cytokine 2005, 32, 85-93
38. Cheung, M. C.; Brown, B. G.; Marino Larsen, E. K.; Frutkin, A. D.; OBrien, K. D.; Albers, J. J. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease Biochim. Biophys. Acta 2006, 1762, 131-137
39. Marchesi, J. R.; Holmes, E.; Khan, F.; Kochhar, S.; Scanlan, P.; Shanahan, F.; Wilson, I. D.; Wang, Y. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease J. Proteome Res. 2007, 6, 546-551
40. Jansson, J.; Willing, B.; Lucio, M.; Fekete, A.; Dicksved, J.; Halfvarson, J.; Tysk, C.; Schmitt-Kopplin, P. Metabolomics reveals metabolic biomarkers of Crohns disease PLoS One 2009, 4, e6386
41. Le, G. G.; Noor, S. O.; Ridgway, K.; Scovell, L.; Jamieson, C.; Johnson, I. T.; Colquhoun, I. J.; Kemsley, E. K.; Narbad, A. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome J. Proteome Res. 2011, 10, 4208-4218
42. 1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model Arch. Pharm. Res. 2010, 33, 1091-1101
43. Souba, W. W.; Smith, R. J.; Wilmore, D. W. Glutamine metabolism by the intestinal tract JPEN, J. Parenter. Enteral Nutr. 1985, 9, 608-617
44. Hering, N. A.; Schulzke, J. D. Therapeutic options to modulate barrier defects in inflammatory bowel disease Dig. Dis. Sci. 2009, 27, 450-4
45. Ren, S.; Kim, J. K.; Kakiyama, G.; Rodriguez-Agudo, D.; Pandak, W. M.; Min, H. K.; Ning, Y. Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3beta,25-diol, disulfate PLoS One 2014, 9, e103621
46. Chu, C. C.; Hou, Y. C.; Pai, M. H.; Chao, C. J.; Yeh, S. L. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis J. Nutr. Biochem. 2012, 23, 1092-9
47. Peters, J. H.; Beishuizen, A.; Keur, M. B.; Dobrowolski, L.; Wierdsma, N. J.; van Bodegraven, A. A. Assessment of small bowel function in critical illness: potential role of citrulline metabolism J. Intensive Care Med. 2011, 26, 105-110
48. Werner, T.; Haller, D. Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanisms Mutat. Res. 2007, 622, 42-57
49. Shkoda, A.; Werner, T.; Daniel, H.; Gunckel, M.; Rogler, G.; Haller, D. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease J. Proteome Res. 2007, 6, 1114-1125
50. Rocha, R.; Santana, G. O.; Almeida, N.; Lyra, A. C. Analysis of fat and muscle mass in patients with inflammatory bowel disease during remission and active phase Br. J. Nutr. 2009, 101, 676-9
51. Al-Jaouni, R.; Hebuterne, X.; Pouget, I.; Rampal, P. Energy metabolism and substrate oxidation in patients with Crohns disease Nutrition 2000, 16, 173-8
52. Mingrone, G.; Greco, A. V.; Benedetti, G.; Capristo, E.; Semeraro, R.; Zoli, G.; Gasbarrini, G. Increased resting lipid oxidation in Crohns disease Dig. Dis. Sci. 1996, 41, 72-6
53. Buhner, S.; Nagel, E.; Korber, J.; Vogelsang, H.; Linn, T.; Pichlmayr, R. Ileal and colonic fatty acid profiles in patients with active Crohns disease Gut 1994, 35, 1424-8
54. Lands, W. E.; Inoue, M.; Sugiura, Y.; Okuyama, H. Selective incorporation of polyunsaturated fatty acids into phosphatidylcholine by rat liver microsomes J. Biol. Chem. 1982, 257, 14968-72